Cytarabine (Low-Dose)
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Cytarabine (Low-Dose), covering 2015-06-24 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]